China biotech Junshi Biosciences seeks up to $414 million in Hong Kong IPO: Reuters

Chinese biotech company Shanghai Junshi Biosciences is seeking up to $414 million in a Hong Kong initial public offering (IPO), making it the latest company to take advantage of new listing rules to attract early-stage drug developers, Reuters reported.